Wellnex Life reports 40% revenue jump, narrows normalized losses

Wellnex Life Limited (ASX/AIM:WNX) reported preliminary fiscal year 2025 results, showcasing a 40.4% increase in total revenue to $23.6 million and a 38.4% rise in gross profit to $6.9 million, alongside a 57% improvement in normalized EBITDA loss to $2.2 million. Despite these operational gains, the company posted a net loss of $15.6 million, primarily impacted by $11.7 million in non-cash and one-off expenses related to brand operations and its dual listing. Net assets grew 85.6% to $11.3 million, with gross margins improving in the second half, and Wellnex anticipates continued revenue growth and margin expansion through planned growth initiatives and licensing opportunities in fiscal 2026.

Analysis

Wellnex Life Limited (WNX) has reported strong top-line growth in its preliminary, unaudited fiscal 2025 results, with total revenue increasing 40.4% to $23.6 million and gross profit rising 38.4% to $6.9 million. While the company posted a significant net loss of $15.6 million, this figure is heavily skewed by $11.7 million in non-cash and one-off expenses attributed to brand operations and its dual listing on AIM. A more indicative measure of operational health is the normalized EBITDA loss, which improved by 57% to $2.2 million from the prior year. A key operational dynamic was the tale of two halves for gross margins: a dip to 23% in the first half due to a one-off trade investment was followed by a substantial recovery to 37% in the second half, suggesting improved cost discipline. The company's balance sheet strengthened, with net assets growing 85.6% to $11.3 million. Management's outlook for fiscal 2026 is positive, citing planned growth initiatives and licensing opportunities to further drive revenue and expand margins.

Key Decisions for Investors

• Investors should look past the headline net loss and focus on the 57% improvement in normalized EBITDA and strong revenue growth as more relevant indicators of underlying business performance.
• The significant gross margin improvement to 37% in the second half is a critical positive, but its sustainability must be monitored in subsequent quarters to confirm a structural improvement in profitability.
• Given the results are preliminary and unaudited, it is crucial to await the final audited financials to confirm these figures and check for any material adjustments.
• The company's valuation will be highly dependent on the successful execution of its stated growth and licensing initiatives for fiscal 2026; progress on these fronts should be closely tracked.